Emergent BioSolutions
(NYSE) EBS
Emergent BioSolutions Financials at a Glance
Market Cap
$467.38M
Revenue (TTM)
$676.80M
Net Income (TTM)
$8.60M
EPS (TTM)
$-0.28
P/E Ratio
-32.00
Dividend
$0.00
Beta (Volatility)
1.78 (High)
Dividend
$0.00
Beta (Volatility)
1.78 (High)
Price
$9.05
Volume
1,336,892
Open
$8.69
Price
$9.05
Volume
1,336,892
Open
$8.69
Previous Close
$9.05
Daily Range
$8.67 - $9.54
52-Week Range
$4.71 - $14.06
Dividend
$0.00
Beta (Volatility)
1.78 (High)
Price
$9.05
Volume
1,336,892
Open
$8.69
Previous Close
$9.05
Daily Range
$8.67 - $9.54
52-Week Range
$4.71 - $14.06
EBS News
EBS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Emergent BioSolutions
Industry
Biotechnology
Sector
Health CareEmployees
900
CEO
Joseph C. Papa, MBA
Website
www.emergentbiosolutions.comHeadquarters
Gaithersburg, MD 20879, US
EBS Financials
Key Financial Metrics (TTM)
Gross Margin
44%
Operating Margin
11%
Net Income Margin
-1%
Return on Equity
-2%
Return on Capital
6%
Return on Assets
-1%
Earnings Yield
-3.13%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$467.38M
Shares Outstanding
51.64M
Volume
1.34M
Avg. Volume
870.13K
Financials (TTM)
Gross Profit
$350.60M
Operating Income
$110.20M
EBITDA
$208.50M
Operating Cash Flow
$170.60M
Capital Expenditure
$13.80M
Free Cash Flow
$156.80M
Cash & ST Invst.
$205.40M
Total Debt
$572.10M
Emergent BioSolutions Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$156.10M
-29.7%
Gross Profit
$67.60M
-42.0%
Gross Margin
43.31%
N/A
Market Cap
$467.38M
N/A
Market Cap/Employee
$519.31K
N/A
Employees
900
N/A
Net Income
$6.80M
-90.0%
EBITDA
$34.60M
-53.6%
Quarterly Fundamentals
Net Cash
$413.30M
+20.0%
Accounts Receivable
$121.60M
-40.3%
Inventory
$327.60M
+4.3%
Long Term Debt
$573.60M
-13.8%
Short Term Debt
$0.00
N/A
Return on Assets
-0.65%
N/A
Return on Invested Capital
6.08%
N/A
Free Cash Flow
$36.20M
-144.6%
Operating Cash Flow
$33.80M
-201.8%